SRC Patient Profiles - Auburn University | College of Veterinary Medicine
Auburn University Vet Med logo.
  1. Southeastern Raptor Center Home
  2. Patient List
2026-023 Problems Notes Costs
Admission date2026-01-25
Final date -
Days in captivity27
SpeciesEASO - Eastern screech owl
AgeAHY
SexUNK
StatusReh
Band
Evisceration, OD
Ocular - blind, OD
Ocular - retinitis, OS
Ocular - uveitis, OD
Ocular - uveitis, OS
Ocular-lens luxation OD

Cause of injury: Collision - Vehicle, suspected

Ophtho - Reheck wk Feb 23rd

Found in Roanoke,AL
Randolph county
Here is a summary of this patient's treatments and expenses:

Desc Qty Cost Subtotal
Examination175.0075.00
Daily rate2710.00270.00
Complete blood count158.0058.00
Packed cell volume18.078.07
Blood chemistry145.3545.35
Eye exam225.0050.00
Lab tests1Variable40.00
Total  546.42

Costs are estimates based on fees charged at a local avian specialist.
Radiographs and images
No images for this patient
2026-02-20 15:46 RE

======= TREATMENT PLAN =======
Food: 20g M SID
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO
==============================
d/c bupe

2026-02-20 15:43 RE

Food: 23g M
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-20 10:40 RE

Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

BAR, 2 pellets, normal mutes, 4g leftovers

2026-02-19 16:42 KT

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-19 11:01 KT

TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

BAR, Normal Mutes, Pellet, No Leftovers

2026-02-18 16:32 KT

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-18 10:18 KT

TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

BAR, Normal Mutes, Pellet, 4g Leftovers

2026-02-17 16:40 RE

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-17 10:09 kmh
Weight: 131 grams
Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

BAR, 2P, 10G leftover, NM

2026-02-16 16:52 KT

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO until 2026-02-19
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-16 13:10 SAK

======= TREATMENT PLAN =======
Food: 20g M SID
TMS: 0.12 ml (48 mg/ml) BID PO until 2026-02-19
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO
==============================
D/C TMS on 2/19

2026-02-16 09:17 SAK

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

No leftover, 1 pellet, Normal Mutes

2026-02-15 16:09 MR

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-15 11:53 SAK

Swelling of surgery site with fluid. Gentle pressure and blood/fluid came out of choana. Notified Dr. S.

2026-02-15 11:53 SAK

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

No leftovers, 1 pellet, normal mutes

2026-02-14 16:19 RE

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO

2026-02-14 15:35 RE

======= TREATMENT PLAN =======
Food: 20g M SID
TMS: 0.12 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO
==============================
d/c ketorolac

2026-02-14 12:48 kmh

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -
BAR, 1P, NM, 0LO

2026-02-13 16:33 SAK

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-13 08:00 RE

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, no pellet, normal mutes, 13g leftovers

2026-02-12 17:06 RE

Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ

2026-02-12 16:36 KT

Food: 21g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-12 10:00 KT

TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, Pellet, Normal Mutes, 3g Leftovers

2026-02-11 16:37 KT

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-11 12:12 RE

Surgery report
Procedure - Evisceration
Performed by - Huang
Surgery time - 0 minutes

Standard sterile preparation with careful plucking of the feathers
along and adjacent to the eyelid margins performed. A limbal
stab
incision was made dorsotemporally with a beaver no. 65 blade
parallel to the iris. The cornea was excised 360° with left and
right
corneal scissors. A cyclodialysis spatula was used to bluntly
dissect the uvea from the sclera. The iris, lens, vitreous body,
retina,
and uvea were then removed by using gentle blunt dissection with
a evisceration spoon and sterile cotton-tipped applicators until
only the white sclera was visible. The eyelid margins were excised
with metzenbaum scissor, taking care to ensure the superior
and inferior nasolacrimal puncta were intact. The third eyelid
and conjunctival tissue were left in place. The site was closed
in 1
layers in a simple continuous pattern with 5–0 PDS. Skin glue
1 drop was placed on lateral canthus. Patient was inadvertantly
extubated peri-op during skin closure with contamination of sterile
field from draping; cefazolin was given peri-op.

2026-02-11 10:52 KT

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, No Pellet, 6g leftovers, Normal Mutes

2026-02-10 16:12 RE

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-10 11:59 KT
Weight: 133 grams
TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, Normal Mutes, Pellet, No leftovers

Wt. gain 2% bw

2026-02-09 16:29 KT

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-09 10:30 SAK

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

No leftovers, 1 pellet, normal mutes

2026-02-08 16:05 KT

Food: 19g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-08 10:30 KT

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, N/M, No Pellet, No LO

2026-02-07 17:25 RE

Food: 19g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-07 13:08 RE

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, one pellet, normal mutes, no leftovers

2026-02-06 17:24 RE

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-06 09:30 add

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

BAR, NP, NM, NOLO

2026-02-05 16:52 RE

Food: 21g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OD -

2026-02-05 16:19 SAK

======= TREATMENT PLAN =======
Food: 20g M SID
TMS: 0.12 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO
Ketorolac - OD BID -
==============================

2026-02-05 15:17 RE

Treatment: OD evisceration ASAP, ketorolac OD BID, finish TMS course (2 weeks)

Eye exam
Exam date - 2026-02-05
Examiner - RE
RIGHTLEFT
PLRMenacePLRMenace
NEGDNE+DNE
Stain Stain 
NEG NEG 
Right eye:
Blepharospasm: 2+, soft globe; AntCh:2+ flare, 2+ cell, anterior lens luxation; Cornea: KP ventrally; Iris: anterior fibrin and synechia; Lens: anterior lens luxation
Left eye:
AntCh: clear and formed; Fundus: blunted ecten, focal depigmentation.

2026-02-05 09:00 RE

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, normal mutes, no pellet, 2g leftovers

2026-02-04 17:00 SAK

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

2026-02-04 12:02 RE

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, no leftovers, 2 pellets, normal mutes

2026-02-03 17:26 RE

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

2026-02-03 11:31 KT
Weight: 131 grams
TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, No Pellet, N/M, No LO

Weight gain 17% BW

2026-02-02 11:08 SAK

TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

2026-02-02 11:05 SAK

0 leftovers, 1 pellet, normal mutes

2026-02-01 16:01 JRW

Food: 20 g M
TMS: 0.12 mL (48 mg/mL) PO
Meloxicam: 0.08 mL (1.5 mg/mL soln) PO
Ketorolac - OU -

2026-02-01 09:08 JRW

Food: 20 g M
TMS: 0.12 mL (48 mg/mL) PO
Buprenorphine SR: 0.02 mL (1.8 mg/mL SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -
BAR, normal mutes, no pellet, no LO

2026-01-31 15:45 EL

Food: 20g M
TMS: 0.12 ml (48 mg/ml) PO
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

2026-01-31 11:04 EL

Food: 19g M
TMS: 0.12 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, normal mutes, 1 pellet, no leftovers

2026-01-30 17:57 SAK

======= TREATMENT PLAN =======
Food: 20g M SID
TMS: 0.12 ml (48 mg/ml) BID PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO
Ketorolac - OU BID -
==============================

2026-01-30 16:55 JRW

Food: 60 g M
Meloxicam: 0.08 ml (1.5 mg/mL soln) PO
Ketorolac - OU -

2026-01-30 10:27 EL

Food: 23g M
TMS: 0.11 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, normal mutes, no pellet, no leftovers

2026-01-29 16:55 EL

Food: 22g M
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

2026-01-29 09:46 EL

Food: 22g M
TMS: 0.11 ml (48 mg/ml) PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, normal mutes, 1 pellet, no leftovers

2026-01-29 09:18 KT

======= TREATMENT PLAN =======
Food: 20g M SID
TMS: 0.11 ml (48 mg/ml) SID PO
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO
Ketorolac - OU BID -
==============================

2026-01-28 16:16 EL

Food: 20g M
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO (Give orally until eating on own.)
Ketorolac - OU -

2026-01-28 08:55 EL

Food: 17 g M
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO
Ketorolac - OU -

BAR, normal mutes, no pellet, no leftovers

2026-01-28 08:39 KT

======= TREATMENT PLAN =======
Food: 20g M SID
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO (Give orally until eating on own.)
Ketorolac - OU BID -
==============================

2026-01-27 16:25 JRW

Food: 1 whole M
Assisted feed: 10 g M cut up small pieces
Buprenorphine SR: 0.02 mL (1.8 mg/mL SR) SQ
Meloxicam: 0.08 mL (1.5 mg/mL soln) PO (Give orally until eating on own.)
Ketorolac - OU -

2026-01-27 11:23 JRW

Food: 1 whole M
Assisted feed: 19 g M cut up small pieces
Meloxicam: 0.08 mL (1.5 mg/mL soln) PO (Giving orally until eating on own.)
Ketorolac - OU -

2026-01-26 23:23 EL

Presence of toxic heterophils and the presence of granulomatous change in the retina OS led to patient being placed on oral SMZ. Also concern that there may be perforation OD, prevent pre-operative infection of globe.

CBC
Collection date2026-01-27
WBC count5102
Corrected count5102
Hets/Neut41% - 2091
  Bands0+
  Toxics3+
Lymphs51% - 2602
Eos2% - 102
Mono6% - 306
Baso0% - 0
ThrombocytesAdequate
PI1
HemoproteusNEG
LeukocytozoonNEG
PlasmodiumNEG
Read byMoichor
2+ polychromasia RBC morphology - minimal anisocytosis WBC morphology - mild to moderate toxic chage, cytoplasmic basophilia, toxic granules Lymphocyte morphology - mature, small Hemoparasites - none

2026-01-26 17:00 EL

PCV/TP
Collection date2026-01-26 16:00:00
PCV32 %
TS4.4 g\dl
Serum
Serum chemistry
Collection date2026-01-26
AST1009 U/LPhos6.1 mg/dl
BA0 umol/LTP4.2 g/dl
CK4778 U/LAlb2.6 g/dl
UA13.2 mg/dlGlob1.5 g/dl
Glu312 mg/dlK+6.1 mmol/l
Ca9.8 mg/dlNa+158 mmol/l
  AMY0 U/L
Hem 3, Lip 3, Ict 0

2026-01-26 16:34 EL

Assisted feed: 10g M cut up small pieces
SQ fluids: 7ml LRS until 2026-01-26
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO (Give orally until eating on own.)
Ketorolac - OU -

2026-01-26 11:34 add

Dx: Non functional OD, lens lux OD, severe uveitis OD, mild uveitis OS with vitreal presentation, raised grey lesion retina OS infectious?
Hold off on evisceration until bloodwork/recheck ophtho exam

Eye exam
Exam date - 2026-01-26
Examiner - add
RIGHTLEFT
PLRMenacePLRMenace
DNEDNE++
Stain Stain 
NEG NEG 
Right eye:
Palpebral + Photopic NF Blepharospasm 4+ Retropulsion --soft 3+ flare 4+ cell Complete lens luxation cannot visualize fundus
Left eye:
Palpebral + Dazzle + Photopic F Trace flare, vitreal presentation with pigmented cell on posterior lens capsule Peripheral depigmented lesions around pecten. Grey raised fuzzy margined lesion subretinal infiltrate.

2026-01-26 10:25 EL

Food: 1 whole M
Assisted feed: 10g M cut up small pieces
SQ fluids: 7ml LRS until 2026-01-26
Meloxicam: 0.08 ml (1.5 mg/ml soln) PO (Give orally until eating on own.)
Ketorolac - OU -

2026-01-26 09:49 SAK

======= TREATMENT PLAN =======
Food: 1 whole M SID
Assisted feed: 10g M cut up small pieces BID
Buprenorphine SR: 0.02 ml (1.8 mg/ml SR) SID SQ
Meloxicam: 0.08 ml (1.5 mg/ml soln) BID PO (Give orally until eating on own.)
Ketorolac - OU BID -
==============================

2026-01-26 08:47 add

Ophtho consult revealed that there is an abnormal area of retina in the left eye which they suspected to be infectious in nature (specifically they described it likely to be granulomatous). With the right eye unable to be salvaged and requiring evisceration, patient requires treatment and recheck with ophtho prior to scheduling surgery date.

2026-01-25 16:23 add
Weight: 112 grams, BCS: 2.5

------------- PHYSICAL EXAM FINDINGS ----------------
Attending Veterinarian: Dr. Abigail Duvall
Observational examination
Mentation: QAR
Posture: Upright
Vital stats
Heart rate: 350 bpm
Respiratory rate: 60 bpm
Auscultation: WNL
Mucous membranes: Pink
Hydration: <5%
Comments: Possible shock, not tacky mm/does not appear dehydrated
Choana: Blood in choana when swabbing for AI
Eyes: Severe trauma throughout posterior and anterior chamber OD. Complete detachment of lens/disruption of iris/hyphema/cannotvisualize posterior chamber. OS appears to have some debris in posterior chamber but no hemorrhage/detachment noted. Negative fluorescein stain OU.
Ears: Ad hemorrhage. AS wnl.
Feather quality: Good overall
Integument: Hippoboscid flies
Wings: WNL bilaterally
Wings - Range of motion: WNL
Wings - Patagium: WNL
Legs/Feet - Range of motion: wnl
Neurologic: QAR, bites when handled
BCS: 2
Vent: Clean
Uropygial gland: wnl
Problem list: Severe trauma throughout anterior and posterior chamber OD--lens luxation/avulsion, disruption of iris, hyphema
OS some mild posterior segment debris
Blood AD
Hippoboscid flies
Diagnosis: Severe trauma OD, eye will require enucleation
Mild trauma OS
Hippoboscid flies
Assessment: Overall patient stable, does not appear dehydrated but has suffered significant right sided ocular trauma that will require removal of this eye.

Plan: Tx:
Insect liquidator for hippoboscids
Fluorescein negative OU
Ketorolac OU
Meloxicam 1 mg/kg IM q12
Buprenorphine SR 0.3 mg/kg SC q24
Fluids 60 ml/kg SC q24 7 ml

Dx:
Ophtho consult

Offered 8 g food overnight
Prognosis: Good

2026-01-25 12:16 RE

Sample
Collection date2026-01-25
Typechoanal/cloacal swab
Notes:
Results:
AI PCR : Not detected

Version 4.0.4 - 4.1.13 Sat Feb 21 03:00:12 2026